JPMorgan Chase & Co. Reiterates €59.60 Price Target for Gerresheimer (ETR:GXI)

JPMorgan Chase & Co. set a €59.60 ($69.30) price target on Gerresheimer (ETR:GXI) in a research note published on Friday, Borsen Zeitung reports. The firm currently has a neutral rating on the stock.

GXI has been the subject of several other reports. HSBC set a €85.00 ($98.84) price objective on shares of Gerresheimer and gave the stock a buy rating in a research note on Monday, October 14th. Goldman Sachs Group set a €65.00 ($75.58) price objective on shares of Gerresheimer and gave the stock a neutral rating in a research note on Tuesday, November 19th. Credit Suisse Group set a €87.00 ($101.16) target price on shares of Gerresheimer and gave the company a buy rating in a research note on Tuesday, October 15th. DZ Bank restated a neutral rating on shares of Gerresheimer in a research note on Friday, October 11th. Finally, Deutsche Bank set a €80.00 ($93.02) target price on shares of Gerresheimer and gave the company a buy rating in a research note on Wednesday, November 20th. Two research analysts have rated the stock with a sell rating, four have assigned a hold rating and four have issued a buy rating to the company’s stock. The stock has a consensus rating of Hold and an average target price of €70.96 ($82.51).

GXI remained flat at $€64.10 ($74.53) during trading on Friday. 93,666 shares of the company’s stock traded hands, compared to its average volume of 140,925. The company has a current ratio of 0.81, a quick ratio of 0.54 and a debt-to-equity ratio of 65.99. Gerresheimer has a 12 month low of €56.50 ($65.70) and a 12 month high of €74.80 ($86.98). The stock’s 50-day moving average is €67.36 and its 200 day moving average is €68.23. The stock has a market capitalization of $2.01 billion and a price-to-earnings ratio of 9.72.

Gerresheimer Company Profile

Gerresheimer AG manufactures and sells specialty glass and plastic products primarily for the pharma and healthcare industry worldwide. It operates through three divisions; Plastics & Devices, Primary Packaging Glass, and Advanced Technologies. The Plastics & Devices division offers drug delivery systems, including inhalers, pen systems, and injection systems; sterile and non-sterile prefillable syringe systems for the pharmaceutical and biotech industries; and disposables for various analysis systems that are used in laboratories and medical practices, quick tests for patients in medical practices or hospitals, skin-prick aids and lancets for diabetics, disposables and components for dialysis machines, and catheters and surgical devices.

Featured Story: Stocks at 52 Week High

Analyst Recommendations for Gerresheimer (ETR:GXI)

Receive News & Ratings for Gerresheimer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Gerresheimer and related companies with MarketBeat.com's FREE daily email newsletter.